Newsroom
October 16, 2023
The Mays Cancer Center at UT Health San Antonio will host the third annual San Antonio Liver Cancer Symposium on October 20 and 21 at the Hilton San Antonio Hill Country. The two-day event will bring together health care professionals from around the world to discuss new research and developments in treating liver cancer. The […]
October 16, 2023
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, Oct. 16, 2023 – Mays Cancer Center at UT Health San Antonio will host the third annual San Antonio Liver Cancer Symposium on October 20 and 21 at the Hilton San Antonio Hill Country. The two-day event will bring together health care professionals from around the world to […]
October 6, 2023
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto is a novel targeted molecular therapy that delivers radiation treatment […]
October 6, 2023
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, Oct. 6, 2023 – The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto […]
September 26, 2023
Contacts: Monica Taylor, 210-450-8970, taylorm1@uthscsa.edu, Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO – Children with cancer were joined by their families as they dipped their hands in finger paint and left their mark on a new Hyundai SUV at The University of Texas Health Science Center at San Antonio’s (UT Health San Antonio) Greehey Children’s Cancer Research […]
September 22, 2023
Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, introduces the newest technology in treating prostate cancer. This innovative method is called stereotactic body radiation therapy (SBRT), a minimally invasive therapy using high amounts of radiation with millimeter precision to destroy tumors in the prostate. Stereotactic body radiation therapy is a […]
